National Institute Of Cardiovascular Diseases, Pakistan
Clinical trials sponsored by National Institute Of Cardiovascular Diseases, Pakistan, explained in plain language.
-
Could a cheap heart drug prevent 'No-Reflow' during heart attack treatment?
Disease control Recruiting nowThis study tests whether giving the drug adenosine just before emergency angioplasty (PCI) can improve blood flow in heart attack patients. About 1,148 adults having a severe type of heart attack (STEMI) will either receive adenosine or standard care. The goal is to see if adenos…
Phase: PHASE4 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a balloon replace stents in young heart attack patients?
Disease control Recruiting nowThis study compares a drug-coated balloon to a standard drug-eluting stent in 496 young adults (ages 18–50) having a heart attack. The balloon delivers medication to open the artery without leaving a permanent implant, which may reduce long-term risks like blood clots and the nee…
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
10,000 volunteers join quest to predict heart attacks before they strike
Knowledge-focused Recruiting nowThis study is testing two simple risk score tools to see how well they predict heart disease in 10,000 people in Pakistan. Participants will have their risk factors checked and be followed over time. The goal is to find the best way to identify who needs early treatment to preven…
Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC